Skip to main content
. 2013 May 13;1:16. doi: 10.1186/2051-5960-1-16

Table 1.

Pathological, clinical and genetic info of human brain samples used

 
 
Clinical info
Genetic info
Origin Pathological diagnosis*1 Clinical diagnosis Sub-class Gender Age at onset Age at death Fam/Spor Pathogenic Mutation TMEM106B rs19906222 GRN rs58483 C9ORF72 SORT14 RNA quality ok
VIB
Def. Control
N.A.
N.A.
m
N.A.
78.1
N.A.
N.A.
CT
CC
no
AG
yes
VIB
Def. Control
N.A.
N.A.
m
N.A.
66.3
N.A.
N.A.
CT
CC
no
AA
yes
VIB
Def. Control
N.A.
N.A.
m
N.A.
73.3
N.A.
N.A.
TT
TC
no
AA
yes
VIB
Def. Control
N.A.
N.A.
f
N.A.
62.7
N.A.
N.A.
TT
TC
no
AA
yes
VIB
Def. Control
N.A.
N.A.
m
N.A.
64.6
N.A.
N.A.
CT
TT
no
AG
yes
MRC
Def. Control
N.A.
N.A.
m
N.A.
77
N.A.
N.A.
CC
TC
no
AG
yes
MRC
Def. Control
N.A.
N.A.
m
N.A.
66
N.A.
N.A.
CT
CC
no
AG
yes
MRC
Def. Control
N.A.
N.A.
m
N.A.
54
N.A.
N.A.
TT
CC
no
AA
yes
MRC
Def. Control
N.A.
N.A.
m
N.A.
59
N.A.
N.A.
TT
TC
no
AG
yes
MRC
Def. Control
N.A.
N.A.
m
N.A.
55
N.A.
N.A.
CC
CC
no
AA
yes
MRC
Def. Control
N.A.
N.A.
m
N.A.
67
N.A.
N.A.
CT
TC
no
AA
yes
MRC
Def. Control
N.A.
N.A.
m
N.A.
78
N.A.
N.A.
CT
CC
no
AA
yes
MRC
Def. Control
N.A.
N.A.
m
N.A.
79
N.A.
N.A.
TT
TC
no
AG
yes
MRC
Def. Control
N.A.
N.A.
m
N.A.
50
N.A.
N.A.
TT
CC
no
AA
yes
MRC
Def. Control
N.A.
N.A.
m
N.A.
82
N.A.
N.A.
CT
CC
no
AG
yes
VIB
FTLD-TDP
MXD
N.A.
m
72
83
S
no
CT
CC
no
AA
yes
VIB
FTLD-TDP B
FTLD
FTD
m
47
50
F
no
CT
CC
no
AG
yes
VIB
FTLD-TDP
FTLD
prob AD
f
80
88
F
no
CT
TT
no
AA
yes
VIB
FTLD-TDP B
FTLD-ALS
FTD-ALS
m
59
62
S
no
CT
CT
no
AG
yes
VIB
FTLD-TDP D
FTLD
FTD
f
44
56
F-AD
VCP Arg159His5
TT
TC
no
AA
yes
VIB
FTLD-TDP D
FTLD
FTD
m
63
68
F-AD
VCP Arg159His5
CT
TT
no
AA
yes
VIB
FTLD-TDP A
FTLD
N.A.
f
62
68
F-AD
GRN IVS1 + 5G > C6
CT
TC
no
AA
yes
VIB
FTLD-TDP A
FTLD
N.A.
f
58
63
F-AD
GRN IVS1 + 5G > C6
TT
TC
no
AG
yes
VIB
FTLD-TDP A
FTLD
N.A.
m
57
62
F-AD
GRN IVS1 + 5G > C6
CT
TC
no
AG
yes
VIB
FTLD-TDP A
FTLD
FTD
f
69
75
F-AD
GRN IVS1 + 5G > C6
TT
TC
no
AA
yes
MRC
FTLD-TDP B
FTLD
FTD + MND
m
43
45
S
no
CT
CC
no
AG
yes
MRC
FTLD-TDP B
FTLD
FTD + MND
m
65
67
S
no
CC
CC
no
AG
yes
MRC
FTLD-TDP B
FTLD
FTD + MND
m
74
76
S
no
TT
TC
no
AG
no
MRC
FTLD-TDP B
FTLD
FTD
m
60
68
S
no
TT
CC
no
AA
yes
MRC
FTLD-TDP B
FTLD
FTD
m
45
51
S
no
CT
TT
no
AG
yes
MRC
FTLD-TDP B
FTLD
FTD
m
59
66
S
no
TT
CC
no
AA
yes
MRC
FTLD-TDP B
FTLD
FTD + MND
m
58
69
S
no
CC
CC
no
AA
yes
MRC
FTLD-TDP B
FTLD
FTD
m
58
66
S
no
CT
CC
no
AG
no
MRC
FTLD-TDP B
FTLD
FTD/SD
m
68
74
S
no
TT
CC
no
AA
yes
MRC
FTLD-TDP B
FTLD
MND
m
N.A.
71
S
N.A.
TT
TC
no
AA
no
VIB
AD-CAA
Prob AD
 
f
61
75
F
APP -369C/G7
CT
CC
no
AG
yes
VIB
AD
Prob AD
 
f
-
85
S
no
CT
TC
no
AA
no
VIB
AD
Prob AD
 
m
80
86
S
no
TT
TC
no
AG
yes
VIB
AD
Prob AD
 
m
87
91
U
no
CC
CC
no
AG
yes
VIB
AD
Prob AD
 
m
67
77
F
no
TT
TC
no
AG
yes
VIB
AD
Prob AD
 
f
64
79
S
no
CT
TT
no
AA
no
VIB
AD
Poss AD
 
m
<84
87
S
no
CT
CC
no
AA
yes
VIB
AD
Prob AD
 
f
50
57
F
PSEN1 P264L8
TT
TC
no
AA
yes
MRC
PD
PD
 
f
45
62
N.A.
N.A.
CC
CC
no
AA
yes
MRC
PD
Dementia
 
f
~84
89
N.A.
N.A.
CT
TC
no
AA
yes
MRC
PD
PD
 
f
~80
85
N.A.
N.A.
CC
CC
no
AG
yes
MRC
PD
PD
 
m
?
73
N.A.
N.A.
CC
CC
no
AG
yes
MRC
PD
?
 
m
?
76
N.A.
N.A.
CC
CC
no
AA
yes
MRC
PD
PD
 
f
76
80
N.A.
N.A.
CT
TC
no
AG
yes
MRC
PD
PD
 
m
66
79
N.A.
N.A.
CT
TC
no
AA
yes
MRC PD PD?/AD   m 82 84 N.A. N.A. CT TC no AA yes

* according to current classification criteria as proposed in [28],

1[29],

2[30],

3[31],

4(van der Zee J. et al., unpublished data),

5[32],

6[10],

7[33],

8[34]

AD Alzheimer’s disease, ALS amyothropic lateral sclerosis, APP amyloid precursor protein, CAA Cerebral Amyloid Angiopathy, F familial, F-AD familial autosomal dominant, IVS splice donor site of intron 1 MND motorneuron disease, MRC Medical Research Council London Neurodegenerative Diseases Brain Bank, MXD mixed dementia, N.A. not applicable, PD Parkinson’s disease, Prob probably, Poss possibly, S sporadic, SD semantic dementia, PSEN1 presenilin 1, U unknown, VIB VIB Department of Molecular Genetics, Antwerp, Belgium.